| 000 | 01392 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513152958.0 | ||
| 264 | 0 | _c19981105 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLu, J | |
| 245 | 0 | 0 |
_aEpithelial ion transport and barrier abnormalities evoked by superantigen-activated immune cells are inhibited by interleukin-10 but not interleukin-4. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cOct 1998 |
||
| 300 |
_a128-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 |
_aEnterotoxins _xpharmacology |
| 650 | 0 | 4 |
_aEpithelial Cells _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-10 _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-4 _xpharmacology |
| 650 | 0 | 4 |
_aIntestinal Mucosa _ximmunology |
| 650 | 0 | 4 |
_aIon Transport _xdrug effects |
| 650 | 0 | 4 |
_aLymphocytes _xphysiology |
| 650 | 0 | 4 |
_aMuromonab-CD3 _ximmunology |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 |
_aSuperantigens _xpharmacology |
| 700 | 1 | _aPhilpott, D J | |
| 700 | 1 | _aSaunders, P R | |
| 700 | 1 | _aPerdue, M H | |
| 700 | 1 | _aYang, P C | |
| 700 | 1 | _aMcKay, D M | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 287 _gno. 1 _gp. 128-36 |
|
| 999 |
_c9730147 _d9730147 |
||